Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci

  • Marianne Horgan
  • , Gary O'Flynn
  • , Jennifer Garry
  • , Jakki Cooney
  • , Aidan Coffey
  • , Gerald F. Fitzgerald
  • , R. Paul Ross
  • , Olivia McAuliffe

Research output: Contribution to journalArticlepeer-review

Abstract

A truncated derivative of the phage endolysin LysK containing only the CHAP (cysteine- and histidine-dependent amidohydrolase/peptidase) domain exhibited lytic activity against live clinical staphylococcal isolates, including methicillin-resistant Staphylococcus aureus. This is the first known report of a truncated phage lysin which retains high lytic activity against live staphylococcal cells.

Original languageEnglish
Pages (from-to)872-874
Number of pages3
JournalApplied and Environmental Microbiology
Volume75
Issue number3
DOIs
Publication statusPublished - Feb 2009

Fingerprint

Dive into the research topics of 'Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci'. Together they form a unique fingerprint.

Cite this